Keyphrases
Homozygous Familial Hypercholesterolemia (HoFH)
78%
Hypercholesterolemia
62%
Plasma Exchange
61%
Fibrinogen
44%
Cholesterol
41%
Erythrocytes
37%
Lovastatin
36%
Lipid Profile
30%
Lipoproteins
29%
Peripheral Blood
28%
Platelets
26%
Adhesiveness
25%
Clinical Course
23%
Israeli
23%
Red Blood Cell Aggregation
23%
Dextran Sulfate Sodium
23%
Insulin Resistance
23%
Lipoprotein Apheresis
22%
Plasma Exchange Therapy
22%
Triglycerides
21%
Cholesterol Levels
20%
Hypertriglyceridemia
19%
Primary Hypercholesterolemia
18%
Hypocholesterolemic
18%
Homocysteine
17%
LDL Apheresis
17%
Coronary Risk Factors
17%
LDL Cholesterol
16%
Blood Rheology
15%
Moderate to Severe
15%
Cardiovascular Risk
15%
Apoprotein
15%
Fish Oil
15%
Drug Therapy
14%
Red Blood Cells
14%
Peripheral Venous Blood
14%
Atherogenesis
14%
Placebo
14%
Coronary Risk
14%
Low-density Lipoprotein Cholesterol (LDL-C)
14%
Lipid Modification
13%
Israel
13%
Catabolism
13%
Cohesive Force
11%
Diclofenac
11%
Homozygous FH
11%
Primary Prevention
11%
Thyrotoxicosis
11%
Low-density Lipoprotein Receptor Gene
11%
Once-daily
11%
Biochemistry, Genetics and Molecular Biology
Blood Plasma
100%
Hypercholesterolemia
52%
Familial Hypercholesterolemia
42%
Low-Density Lipoprotein
29%
Cholesterol Blood Level
26%
Apheresis
25%
Metabolic Pathway
23%
Fibrinogen
23%
Lipid
21%
Lipid Profile
21%
Triglyceride
20%
Lipoprotein
18%
Homocysteine
17%
Cholesterol Level
15%
Hemocyte
14%
Body Weight
14%
Erythrocyte Adhesiveness
14%
Vitamin B12
11%
LDL Receptor
11%
Erythrocyte Aggregation
11%
Folic Acid
11%
Amino Acids
11%
Apolipoprotein
11%
Lovastatin
11%
Hypertriglyceridemia
11%
Fibrinogen Blood Level
11%
Immunoglobulin
11%
Missense Mutation
11%
Statin
11%
Aminolevulinic Acid Synthase
11%
Energy Balance
11%
Energy Transfer
11%
High-Density Lipoprotein
11%
Receptor Gene
11%
C-Reactive Protein
11%
Young Modulus
11%
Sulfate
11%
Arterial Stiffness
11%
Apolipoprotein E
11%
Insulin Resistance
11%
Abetalipoproteinemia
11%
Hemorheology
11%
Dextran
11%
Pulse Wave
8%
HDL-Cholesterol
6%
Triglyceride-Rich Lipoprotein
5%
Turbidity
5%
Cholesterol Synthesis
5%
Leukocyte Count
5%
Radioactivity
5%
Medicine and Dentistry
Hypercholesterolemia
68%
Plasma Exchange
47%
Lovastatin
36%
Familial Hypercholesterolemia
31%
Fibrinogen
29%
Platelet
26%
Coronary Risk
22%
Disease Course
21%
Atherosclerosis
19%
Hyperlipidemia
18%
Low Density Lipoprotein Cholesterol
17%
Hemorheology
14%
Erythrocyte
14%
Drug Therapy
14%
Prematurity
14%
Placebo
13%
Lipoprotein
12%
Pleura Effusion
11%
Diet Therapy
11%
Family History
11%
Eosinophilic
11%
Combination Therapy
11%
Malignant Histiocytosis
11%
LDL Apheresis
11%
Corynebacterium striatum
11%
Primary Hyperparathyroidism
11%
Nicotine Replacement Therapy
11%
Low-Density Lipoprotein
11%
Ascending Aorta
11%
Coronary Artery Disease
11%
Systemic Lupus Erythematosus
11%
Scintigraphy
11%
Transluminal Coronary Angioplasty
11%
Chylous Ascites
11%
Infarction
11%
Restenosis
11%
Mitral Valve Prosthesis
11%
Abetalipoproteinemia
11%
Apoprotein
11%
Myopathy
11%
Sarcoidosis
11%
Hypogammaglobulinemia
11%
Hypercalcaemia
11%
Primary Prevention
11%
Insulin Resistance
11%
Lupus Anticoagulant
11%
Endocarditis
11%
Calcium Channel
11%
Statin
11%
Prostate Adenocarcinoma
11%
